Debut Plus

₹1,509.4

▲ +251.46 +19.99%

As of 09 Sept 2026 · delayed

NSE Listed

Molbio Diagnostics Ltd. (MOLBIO)

Volume: 94,14,132Avg Vol 1W: 23,72,923.4Avg Vol 1M: 35,92,497.8352W Range:₹926.35₹1,509.4
NSE BSE www.molbiodiagnostics.com
Key Ratios
Checked 6h ago
Market Cap₹14,496 Cr
Current Price₹1,509.4
Previous Close₹1,257.94
High / Low (52w)₹1,509.4 / ₹926.35
Volume94,14,132
Avg Vol (1W)23,72,923.4
Avg Vol (1M)35,92,497.83
Stock P/E86.69
Book Value₹118.84
Dividend Yield0%
ROE14.25%
ROA0%
Revenue (TTM)₹1,455 Cr
Revenue Growth—
Profit Margin11.78%
Total Debt—
Shares Outstanding12 Cr
Face Value—
EPS (TTM)₹14.51
P/B10.59
Debt / Equity0.28
50 DMA₹1,126.36
200 DMA₹1,126.36
Day change+19.99%
Price Chart
₹1,509.4▲ 44.90% · 1Y
₹1509₹10371.6Cr
2026-08-17
2026-09-09

20-day avg volume: 35.9L shares

Pros
  • Company is almost debt-free.
Cons
  • Revenue fell 96% YoY.
  • Company is loss-making at the latest annual result.
  • Stock trades at a high P/E of 87.
Quarterly Results
MetricJun 2025Mar 2026Jun 2026
Revenue₹100 Cr₹561 Cr₹408 Cr
EBITDA₹-27 Cr₹144 Cr₹87 Cr
Net Profit₹-24 Cr₹91 Cr₹59 Cr
EPS———
Profit & Loss (Annual)
MetricMar 2022Mar 2023Mar 2024Mar 2025Jun 2025Mar 2026Mar 2026Jun 2026
Revenue₹782 Cr₹337 Cr₹841 Cr₹1,028 Cr₹95 Cr₹1,455 Cr₹439 Cr₹399 Cr
EBITDA₹321 Cr₹16 Cr₹197 Cr₹225 Cr₹-16 Cr₹267 Cr₹100 Cr₹85 Cr
Net Profit₹215 Cr₹-1 Cr₹102 Cr₹145 Cr₹-13 Cr₹167 Cr₹66 Cr₹57 Cr
EPS973.82-0.069.0412.87—14.77——
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹315 Cr₹845 Cr₹940 Cr₹1,034 Cr₹1,221 Cr₹1,462 Cr₹2,148 Cr
Total Liabilities₹440 Cr₹510 Cr₹229 Cr₹297 Cr₹392 Cr₹494 Cr₹840 Cr
Equity₹-125 Cr₹335 Cr₹711 Cr₹737 Cr₹829 Cr₹967 Cr₹1,309 Cr
Total Debt———————
Cash Flow
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹-87 Cr₹480 Cr₹189 Cr₹102 Cr₹53 Cr₹367 Cr₹121 Cr
Investing₹-17 Cr₹-145 Cr₹-88 Cr₹-40 Cr₹-45 Cr₹-123 Cr₹-93 Cr
Financing₹110 Cr₹-204 Cr₹-22 Cr₹18 Cr₹-32 Cr₹-26 Cr₹276 Cr
Free Cash Flow₹-87 Cr₹480 Cr₹189 Cr₹102 Cr₹53 Cr₹367 Cr₹121 Cr
Shareholding
Promoter 41.29% Institutions 17.89% Public 40.82%
Efficiency & Working Capital
ROCE16.2%
Interest Coverage7.9
Dividend Payout—
Debtor Days103 d
Inventory Days113 d
Payable Days50 d
Cash Conversion Cycle166 d
Working Capital Days217 d
Shareholding Details

As of 2026-08-31

Promoter41.3%
FII1.5%
DII16.4%
Institutions17.9%
Public40.8%
Promoter Pledge0%
No. of Shareholders2,33,544
Shareholding Pattern

Quarterly — figures in %. Latest 2 quarters.

PeriodAug 2025Aug 2026
Promoters46.6%41.3%
FIIs0%1.5%
DIIs0%16.4%
Public53.4%40.8%
Promoter Pledge0%0%
No. of Shareholders392,33,544
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Exxora Trading LlpShareholding of Promoter and Promoter Group37.1%4.27 Cr
Business Excellence Trust Iii - India Business ExcPublic Shareholding11.5%1.33 Cr
V-sciences Investments Pte LtdPublic Shareholding8.7%1.01 Cr
Gopalkrishna Mangalore KiniPublic Shareholding5.6%64,62,925
Gopalakrishna SampathgiriPublic Shareholding4.5%52,07,850
Javagal Guru DuttPublic Shareholding4.5%51,61,975
Chandrasekhar Bhaskaran NairShareholding of Promoter and Promoter Group4.2%48,88,850
Usha Rani M APublic Shareholding2.5%28,18,050
Sangeetha Mangalore KiniPublic Shareholding2.3%26,10,000
Rohit Mullangi Ashok KumarPublic Shareholding1.5%16,75,278
Shruthi G KiniPublic Shareholding1.1%12,56,725
Sriram NatarjanShareholding of Promoter and Promoter Group0%0
Sangeetha SriramShareholding of Promoter and Promoter Group0%0
Shiva SriramShareholding of Promoter and Promoter Group0%0
Sowmya SriramShareholding of Promoter and Promoter Group0%0
Sheebani Shiva SriramShareholding of Promoter and Promoter Group0%0
Neelesh PissurlencarShareholding of Promoter and Promoter Group0%0
Tripti PissurlencarShareholding of Promoter and Promoter Group0%0
Shalaka PissurlencarShareholding of Promoter and Promoter Group0%0
Gaurav BaliShareholding of Promoter and Promoter Group0%0
Amyra BaliShareholding of Promoter and Promoter Group0%0
Pushpa BaliShareholding of Promoter and Promoter Group0%0
Seema VermaShareholding of Promoter and Promoter Group0%0
Anita A ChandrasekharShareholding of Promoter and Promoter Group0%0
Thangam BhaskaranShareholding of Promoter and Promoter Group0%0
Board of Directors
NameDesignationYear
SRIRAM NATARAJANExecutive Director & CEO2025
CHANDRASEKHAR NAIRExecutive Director / Chief Technology Officer2025
SANGEETHA SRIRAMExecutive Director (Operation)2025
Arun Kumar JhaIndependent Non Exe. Director2025
Dr Balram BhargavaIndependent Non Exe. Director2025
Nupur GargIndependent Non Exe. Director2025
Darshan Raghunath KarekarCompany Sec. & Compli. Officer2025
Segments — Geography
RegionRevenueShare
India₹776 Cr79.9%
Outside India₹195 Cr20.1%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹12022
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202432000210346
202423700170256
202480004086
Company Information
Incorporated2000
AuditorS R Batliboi & Associates LLP
Investor Email[email protected]
🌐 www.molbiodiagnostics.com ↗

📍 No.L-46 Phase II-D, Verna Industrial Area Verna, Salcete, Goa, 403722

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Modern Threads India Ltd.Mohite Industries Ltd.Mohit Industries Ltd.MOILMoksh Ornaments LimitedMeghmani Organics LimitedMold-Tek Technologies Ltd.Mold-Tek Packaging Ltd.Rays of Belief LimitedMonarch Networth Capital Ltd.Moneyboxx Finance LimitedMonolithisch India Ltd.All “M” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search